Lallemand Pharma and GlaxoSmithKline partner to launch ISMIGEN in Poland
7 January 2011 | By Lallemand Pharma Europe
Lallemand Pharma Europe and GlaxoSmithKline announced the launch of ISMIGEN® in Poland...
List view / Grid view
News
Novozymes Biopharma presents recombinant human albumin research at PepTalk 2011
6 January 2011 | By The Scott Partnership
Novozymes Biopharma is presenting two scientific posters on the manufacturing and use of recombinant albumin in formulation...
Lab21 acquires Microgen Bioproducts
6 January 2011 | By College Hill Ltd
Lab21 Limited, today announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests...
Bicycle Therapeutics appoints Andy Sandham as non-executive Chairman
6 January 2011 | By College Hill Ltd
Bicycle Therapeutics today announced the appointment of Andy Sandham as non-executive Chairman. Andy brings over 30 years experience in building biotechnology businesses...
Avoid Costly Issues within Clinical Trials by Investing in proven Retention and Compliance Solutions, advises Exco InTouch
5 January 2011 | By The Scott Partnership
Increasing trial complexity and duration of studies, patient non-compliance is a growing issue...
Mike Romanos appointed as CEO of Crescendo Biologics
5 January 2011 | By Citigate Dewe Rogerson Ltd
Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer...
Quantum Pharmaceutical Appoints New National Account Manager
5 January 2011 | By Smith & Smith PR
Unlicensed medicines manufacturer Quantum Pharmaceutical has appointed Pauline Carter as its new National Account Manager...
Wyatt Technology MALS detectors used in breakthrough virus research
5 January 2011 | By The Scott Partnership
Landmark study transforms the previous scientific understanding of immunity to viral diseases like the common cold, 'winter vomiting' and gastroenteritis...
eC-SSRS solution from ERT facilitates compliance with new FDA guidance
5 January 2011 | By The Scott Partnership
ERT's eC-SSRS solution facilitates compliance with FDA guidance on suicidality assessment in clinical trials...
arGEN-X signs discovery and development alliance with Lilly
5 January 2011 | By Citigate Dewe Rogerson
arGEN-X BV, announced it has entered into an alliance with Lilly to discover and develop novel therapeutic antibody products against targets submitted by Lilly...
GSK Head of Patient Recruitment Joins Exco InTouch
4 January 2011 | By The Scott Partnership
Exco InTouch, announces the appointment of Judith Teall. The newly created position will drive Exco InTouch to build on its “patient centric” approach to managing clinical trials...
NICE recommends Votrient®▼ (pazopanib) for the first-line treatment of advanced renal cell carcinoma (RCC)
4 January 2011 | By GlaxoSmithKline
Targeted oral treatment slows down the progression of advanced kidney cancer...
AstraZeneca and Abbott end license agreement for the development of Certriad
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...
ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO
21 December 2010 | By The Scott Partnership
ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010...
PharmaNet Offers Guidance on Regulatory Pathway for Biosimilars Development Following Recent FDA Hearing
20 December 2010 | By The Scott Partnership
PharmaNet, are available to offer guidance on the regulatory pathway for biosimilar development...
